Search research articles
Contact Us
Filters
Showing results (281-290 of 368) with videos related to
Page
of 37
Sort By:
Pharmacogenetics and Genomics
|
September 17, 2020
Race and smoking status associated with paclitaxel drug response in patient-derived lymphoblastoid cell lines
Farida S Akhtari, Tammy M Havener, Daniel L Hertz, et al.
International Journal of Legal Medicine
|
September 19, 2015
Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart
C L Hertz, S L Christiansen, L Ferrero-Miliani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 10, 2025
Factors influencing the decision to discontinue treatment due to chemotherapy-induced peripheral neuropathy among patients with metastatic breast cancer: a best-worst scaling
Rotana M Radwan, John F P Bridges, Daniel L Hertz, et al.
Genetics
|
May 9, 2025
Expanding biobank pharmacogenomics through machine learning calls of structural variation
Brett Vanderwerff, Amy L Pasternak, Lars G Fritsche, et al.
Pediatric Radiology
|
December 2, 2000
Intracranial venous anomalies associated with atretic cephalocoeles
F Brunelle, J Baraton, D Renier, et al.
Pharmacogenomics
|
August 2, 2024
Potential association of <i>SULT2A1</i> and <i>ABCG2</i> variant alleles with increased risk for palbociclib toxicity
Chong Wang, Mary Hwang, Brandon Paulson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 21, 2005
CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development
G Pinto, V Abadie, R Mesnage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2013
Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity
Sarah McWhinney-Glass, Stacey J Winham, Daniel L Hertz, et al.
Breast Cancer Research and Treatment
|
April 8, 2014
Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy
Daniel L Hertz, Siddharth Roy, John Jack, et al.
Pharmacogenomics
|
September 13, 2023
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer
Nathan D Seligson, Jill M Kolesar, Benish Alam, et al.
Page
of 37
Search research articles
Search
Showing results (281-290 of 368) with videos related to
Sort By:
Page
of 37
Pharmacogenetics and Genomics
|
September 17, 2020
Race and smoking status associated with paclitaxel drug response in patient-derived lymphoblastoid cell lines
Farida S Akhtari, Tammy M Havener, Daniel L Hertz, et al.
International Journal of Legal Medicine
|
September 19, 2015
Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart
C L Hertz, S L Christiansen, L Ferrero-Miliani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 10, 2025
Factors influencing the decision to discontinue treatment due to chemotherapy-induced peripheral neuropathy among patients with metastatic breast cancer: a best-worst scaling
Rotana M Radwan, John F P Bridges, Daniel L Hertz, et al.
Genetics
|
May 9, 2025
Expanding biobank pharmacogenomics through machine learning calls of structural variation
Brett Vanderwerff, Amy L Pasternak, Lars G Fritsche, et al.
Pediatric Radiology
|
December 2, 2000
Intracranial venous anomalies associated with atretic cephalocoeles
F Brunelle, J Baraton, D Renier, et al.
Pharmacogenomics
|
August 2, 2024
Potential association of <i>SULT2A1</i> and <i>ABCG2</i> variant alleles with increased risk for palbociclib toxicity
Chong Wang, Mary Hwang, Brandon Paulson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 21, 2005
CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development
G Pinto, V Abadie, R Mesnage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2013
Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity
Sarah McWhinney-Glass, Stacey J Winham, Daniel L Hertz, et al.
Breast Cancer Research and Treatment
|
April 8, 2014
Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy
Daniel L Hertz, Siddharth Roy, John Jack, et al.
Pharmacogenomics
|
September 13, 2023
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer
Nathan D Seligson, Jill M Kolesar, Benish Alam, et al.
Page
of 37